Skip to product information
1 of 7

🔥 16 people are currently looking at this product!

ChromaShield-21

ChromaShield-21

When cancer cells die during treatment, they can leave behind microscopic debris that is often reabsorbed into the remaining cancer cells, driving up inflammation and causing treatment resistance. ChromaShield-21 is designed to help your body neutralize that debris — supporting steadier, more compatible recovery conditions during care.

Supports the bodys natural clean-up” process after cancer cell death
Helps reduce inflammation linked to treatment debris
Research-informed microdose resveratrol + copper pairing
Designed to help limit stress on nearby healthy tissue
Precision dosing for compatibility during treatment
Structured to work safely alongside conventional care

Regular price $1.00 USD
Regular price Sale price $1.00 USD
ON SALE TODAY Sold out

Shipping Times

View full details

The Part of TreatmentNobody Talks About: What Happens After Cancer Cells Die

Conventional treatments are designed to destroy cancer cells.

But what happens next also matters.

When those cells die, research shows they can release tiny fragments or debris, called cell-free chromatin particles into the surrounding tissue.

For many patients, this may help explain something familiar:

Why treatment can sometimes feel like it creates a second wave of inflammation or fatigue. Or why cancer can suddenly start behaving more aggressively after treatment starts.

It’s not just the treatment itself.

It’s the “mess”left behind that can create serious problems.

Why This Debris CanMake Recovery Feel Harder

Research suggests this debris can be absorbed by nearby cells and trigger additional inflammatory signaling.

Think of it like extra “noise” in the system — right when your body is already working overtime to heal.

That added burden may make recovery feel tougher than it needs to be, even increasing negative side effects.

Supporting the clean-up phase can help your body stay less inflamed during treatment.

Because healing isn’t only about destroying cancer cells.

It’s also about what happens afterward.

What Studies Showed

In published research, scientists tested ultra-low oral doses of resveratrol combined with copper to see whether they could deactivate cell-free chromatin particles.

In both animal and human studies, this micro-dose approach was associated with calming inflammatory activity and reducing several key signals that help cancer survive and suppress the immune system.

In patients with advanced cancer, researchers observed measurable reductions in cancer-supporting pathways and compounds that hindered the immune system
after these particles were neutralized.

The goal wasn’t to attack cancer directly.

It was to reduce the harmful ripple effects left behind after cell death.

Microdose by Design: Simple, Precise, Compatible

During treatment, more isn’t better.

Intentional is better.

ChromaShield-21 uses precisely structured micro-doses of resveratrol and copper — levels selected specifically to avoid the high antioxidant effects that may conflict with oxidative therapies like chemotherapy or radiation.

At these carefully calibrated doses, it’s targeted, compatibility-first support.

Simple. Measured. Designed to coordinate with yourcare team.

Ready to support your treatment with a simple, doctor-designed approach?

Want to Understand the Full Science First?

If you’d like to see exactly how treatment debris forms — and how this microdose strategy works — we explain everything step-by-step in our free educational training.

In Our Free Training Masterclass, Dr. Thomas walks through:

• Why dying cancer cells can increase inflammation and lead to treatment resistance

• The research behind debris neutralization

• How precision microdosing works differently than typical supplements

Video

Designed to complement conventional care — not replace it.

Always discuss supplements with your oncology team, especially during chemotherapy, radiation, immunotherapy, or prescription use.

FDA Disclaimer:
These statements have not been evaluated by the Food and Drug Administration.
Not intended to diagnose, treat, cure, or prevent any disease.